ロード中...
The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review
Background: Although widely used, first-line injectable medicines for the treatment of multiple sclerosis (MS) remain an issue of efficacy and adherence. Recently, new oral medications for MS have contributed to dramatic improvements in MS treatment. This study aims to evaluate the safety and effica...
保存先:
| 出版年: | Curr J Neurol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Tehran University of Medical Sciences
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8185589/ https://ncbi.nlm.nih.gov/pubmed/38011404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/cjn.v19i3.5427 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|